| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Insider activity in PTGX over the last quarter tilts toward selling: insiders offloaded a net 283,629 shares worth roughly $41.4M. In the past 30 days, 0 insiders bought and 1 sold. The bias lately has been to the sell side.
The insider who sold still holds shares after the sale. Classified under Biotechnology (Health Care sector), PTGX's insider flows are most useful compared with peers in the same group.
| Role | Insider | Shares | Value | 30d |
|---|---|---|---|---|
| CEO | 523.0K | $11.29M | - | |
| Other | 84.1K | $676.3K | - | |
| Dir | 60.8K | $783.7K | - | |
| CFO | 59.0K | $1.38M | -58,629 | |
| Dir | 12.7K | $1.27M | - |
Buys and sells only
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Sep 30, 2026 | Ali Asif | Chief Financial Officer | Sale+OE10b5-1 | 58,629 | $141.78 | $8,312,293.67 | -49.8% | - | - | |
| Sep 10, 2026 | Patel Dinesh V Ph D | President and CEO | Sale+OE10b5-1 | 125,000 | $145.92 | $18,240,567.82 | -19.3% | - | - | |
| Aug 11, 2026 | Patel Dinesh V Ph D | President and CEO | Sale+OE10b5-1 | 100,000 | $148.91 | $14,890,798.99 | -16.0% | - | - | |
| Jun 23, 2026 | Waddill William D.50 | Director | Sale+OE10b5-1 | 9,000 | $117.94 | $1,061,460.00 | -53.5% | +21.9% | - | |
| Jun 10, 2026 | Waddill William D.50 | Director | Sale+OE10b5-1 | 9,000 | $107.68 | $969,120.00 | -53.5% | +38.0% | - | |
| May 29, 2026 | Waddill William D.50 | Director | Sale+OE10b5-1 | 9,000 | $99.64 | $896,760.00 | -53.5% | +50.2% | - | |
| May 12, 2026 | Patel Dinesh V Ph D | President and CEO | Sale+OE | 75,000 | $100.12 | $7,509,000.00 | -12.5% | +50.1% | - | |
| May 8, 2026 | Giraudo Bryan73 | Director | Sale+OE | 59,130 | $100.10 | $5,918,880.00 | -82.3% | +47.1% | - | |
| Apr 20, 2026 | Ali Asif | Chief Financial Officer | Sell | 1,750 | $105.47 | $184,572.50 | -2.9% | +27.3% | - | |
| Mar 26, 2026 | Molina Arturo Md | Chief Medical Officer | Sale+OE | 15,000 | $104.79 | $1,571,850.00 | -15.1% | +19.6% | - |